Celularity Inc. (CELU)
1.70
0.01 (0.59%)
At close: Apr 15, 2025, 3:59 PM
1.67
-1.99%
After-hours: Apr 15, 2025, 05:38 PM EDT
0.59% (1D)
| Bid | 1.53 |
| Market Cap | 40.47M |
| Revenue (ttm) | 48.2M |
| Net Income (ttm) | -35.05M |
| EPS (ttm) | -103.45 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -4.33 |
| Analyst | n/a |
| Ask | 1.75 |
| Volume | 36,768 |
| Avg. Volume (20D) | 157,124 |
| Open | 1.62 |
| Previous Close | 1.69 |
| Day's Range | 1.62 - 1.75 |
| 52-Week Range | 1.00 - 5.22 |
| Beta | 0.58 |
About CELU
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 8, 2019
Employees 120
Stock Exchange NASDAQ
Ticker Symbol CELU
Website https://www.celularity.com
4 months ago
+12.6%
Celularity shares are trading higher. The Nasdaq L...
Unlock content with
Pro Subscription
5 months ago
+113.1%
Celularity shares are trading higher after the company announced it raised its FY24 sales guidance from $50-$60M to $54-$60M.
